Diana De Oliveira Gomes, Shashank S Sinha, Vanessa Blumer
{"title":"When \"not a candidate\" becomes a verdict: Reframing intensive care for patients with advanced heart failure.","authors":"Diana De Oliveira Gomes, Shashank S Sinha, Vanessa Blumer","doi":"10.1016/j.healun.2026.07.023","DOIUrl":null,"url":null,"abstract":"<p><p>The designation \"not an advanced heart failure candidate\" is applied to patients deemed ineligible for heart transplantation or durable left ventricular assist device (LVAD) therapy at a specific point in time. While this designation accurately captures a therapeutic boundary, it is increasingly conflated with broader notions of futility, diminished prognosis, and reduced appropriateness for cardiac intensive care unit (CICU) admission. This conflation is both clinically inaccurate and potentially harmful. Transplant and LVAD candidacy are determined by a narrow, time-sensitive, and often modifiable set of criteria that do not necessarily reflect whether a patient can benefit from invasive hemodynamic monitoring, decongestion, guideline-directed medical therapy initiation, rhythm or conduction interventions, or coronary or peripheral revascularization. Contemporary data demonstrate that acute decompensated heart failure now accounts for most cardiogenic shock cases encountered in contemporary CICUs, a population in which advanced therapy ineligibility is common yet in whom thoughtful critical care may yield meaningful hemodynamic improvement, end-organ recovery, and reassessment of candidacy. This perspective argues for a triage framework that evaluates CICU appropriateness across 3 independent domains: acute physiologic need, reversibility of the index derangement, and longitudinal prognosis aligned with patient preferences. Advanced therapy ineligibility should close one door, not determine how many remain open.</p>","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":" ","pages":""},"PeriodicalIF":6.7000,"publicationDate":"2026-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Heart and Lung Transplantation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.healun.2026.07.023","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
The designation "not an advanced heart failure candidate" is applied to patients deemed ineligible for heart transplantation or durable left ventricular assist device (LVAD) therapy at a specific point in time. While this designation accurately captures a therapeutic boundary, it is increasingly conflated with broader notions of futility, diminished prognosis, and reduced appropriateness for cardiac intensive care unit (CICU) admission. This conflation is both clinically inaccurate and potentially harmful. Transplant and LVAD candidacy are determined by a narrow, time-sensitive, and often modifiable set of criteria that do not necessarily reflect whether a patient can benefit from invasive hemodynamic monitoring, decongestion, guideline-directed medical therapy initiation, rhythm or conduction interventions, or coronary or peripheral revascularization. Contemporary data demonstrate that acute decompensated heart failure now accounts for most cardiogenic shock cases encountered in contemporary CICUs, a population in which advanced therapy ineligibility is common yet in whom thoughtful critical care may yield meaningful hemodynamic improvement, end-organ recovery, and reassessment of candidacy. This perspective argues for a triage framework that evaluates CICU appropriateness across 3 independent domains: acute physiologic need, reversibility of the index derangement, and longitudinal prognosis aligned with patient preferences. Advanced therapy ineligibility should close one door, not determine how many remain open.
期刊介绍:
The Journal of Heart and Lung Transplantation, the official publication of the International Society for Heart and Lung Transplantation, brings readers essential scholarly and timely information in the field of cardio-pulmonary transplantation, mechanical and biological support of the failing heart, advanced lung disease (including pulmonary vascular disease) and cell replacement therapy. Importantly, the journal also serves as a medium of communication of pre-clinical sciences in all these rapidly expanding areas.